Cargando…
Prudent Use of Tylosin for Treatment of Mycoplasma gallisepticum Based on Its Clinical Breakpoint and Lung Microbiota Shift
The aim of this study was to explore the prudent use of tylosin for the treatment of chronic respiratory infectious diseases in chickens caused by Mycoplasma gallisepticum (MG) based on its clinical breakpoint (CBP) and its effect on lung microbiota. The CBP was established based on the wild-type/ep...
Autores principales: | Huang, Anxiong, Wang, Shuge, Guo, Jinli, Gu, Yufeng, Li, Jun, Huang, Lingli, Wang, Xu, Tao, Yanfei, Liu, Zhenli, Yuan, Zonghui, Hao, Haihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458857/ https://www.ncbi.nlm.nih.gov/pubmed/34566919 http://dx.doi.org/10.3389/fmicb.2021.712473 |
Ejemplares similares
-
Rational Use of Danofloxacin for Treatment of Mycoplasma gallisepticum in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift
por: Wang, Shuge, et al.
Publicado: (2022) -
Proteomic analysis of tylosin-resistant Mycoplasma gallisepticum reveals enzymatic activities associated with resistance
por: Xia, Xi, et al.
Publicado: (2015) -
Optimal Regimens and Clinical Breakpoint of Avilamycin Against Clostridium perfringens in Swine Based on PK-PD Study
por: Huang, Anxiong, et al.
Publicado: (2022) -
Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF
por: Xu, Zihui, et al.
Publicado: (2021) -
Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China
por: Mi, Kun, et al.
Publicado: (2021)